Macular Oedema
5 drugs734 FAERS reportsMedDRA PT
GET
/api/v1/reaction/macular-oedemaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Macular Oedema (5)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Omidenepag47.4%
- 2Tropicamide493.1%
- 3Verteporfin382.6%
- 4Ranibizumab5772.2%
- 5Nepafenac662.1%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Cystoid Macular Oedema3 shared · 0.60
- Retinal Detachment2 shared · 0.40
- Age-related Macular Degeneration2 shared · 0.33
- Vitreous Haemorrhage2 shared · 0.33
- Eye Haemorrhage2 shared · 0.25
- Retinal Haemorrhage2 shared · 0.20
- Visual Acuity Reduced5 shared · 0.19
- Vitreous Floaters2 shared · 0.18
- Cataract5 shared · 0.12
- Blindness3 shared · 0.12
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.